Immunogenicity and safety of a 12-valent pneumococcal conjugate vaccine in infants aged 6–10 weeks: a randomized double-blind active-controlled trial
Jonghoon Shin (Shin J), Jamaree Teeratakulpisarn (Teeratakulpisarn J), Thanyawee Puthanakit (Puthanakit T), Tuangtip Theerawit (Theerawit T), Ji Hwa Ryu (Ryu JH), Jinhwan Shin (Shin J), Seulgi Lee (Lee S), Hayoung Lee (Lee H), Kyungjun An (An K), Hun Kim (Kim H)
Clin Exp Pediatr. 2020;63(7):265-271.   Published online 2019 Dec 6     DOI:
Citations to this article as recorded by Crossref logo
Pneumococcal conjugate vaccines: choice of schedule and product development
Jin Lee
Clinical and Experimental Pediatrics.2020; 63(7): 259.     CrossRef